Zulily Inc. (NASDAQ:ZU) is up more than 10% as we type with another 23.55% to go according to Goldman Sachs. Analyst, Taposh Bari upgraded ZU to a "Buy" recommendation from "Neutral" and says the online retailer is headed to fifty bucks.
Zulily operates as an online retailer. The company operates through two segments, North America and the United Kingdom. It provides various merchandise products to moms purchasing for their children, themselves, and their homes, including children's and women's apparel comprising accessories and shoes; children's merchandise comprising infant gear, sports equipment, toys, and books; and other merchandise, such as kitchen accessories, home d茅cor, entertainment, electronics, and pet accessories.
The company sells its products through a flash sales model, which is "an ecommerce business model in which a website offers a single product for sale for a period of 24 to 36 hours," according to Wikipedia.
Top Trucking Stocks For 2015: Sun Life Financial Inc.(SLF)
Sun Life Financial Inc., together with its subsidiaries, provides various life and health insurance, savings, investment management, retirement, and pension products and services to individuals and corporate customers. It offers individual life insurance policies, including individual term life, universal life, critical illness, disability, accident, and accidental death and dismemberment insurance policies; and group life insurance policies. The company also provides individual health insurance, long-term care insurance, group health benefits, dental benefits, and group insurance; and various individual and group annuity, retirement, and investment income products and services, such as mutual and pooled funds, variable and fixed annuities, savings, retirement and pension plans, and education savings. In addition, it offers asset management services for corporate retirement plans, separate accounts, public or government funds, and insurance company assets to institutional clients; and advisory services to individual investors. Further, the company provides run-off reinsurance services. Sun Life Financial Inc. distributes its products through direct sales agents, independent and managing general agents, financial intermediaries, broker-dealers, banks, pension and benefit consultants, and other third-party marketing organizations. The company operates primarily in Bermuda, Canada, China, Hong Kong, India, Indonesia, Ireland, the Philippines, the United States, and the United Kingdom. Sun Life Financial Inc. was founded in 1999 and is based in Toronto, Canada.
Advisors' Opinion:- [By Tim Brugger]
Initially, the deal Sun Life Financial (NYSE: SLF ) struck in December to sell its U.S. annuity portfolio and some life insurance products for $1.35 billion to Delaware Life Holdings, a Guggenheim Partners-owned company, was scheduled to be completed by Q2 of 2013.
- [By Monica Gerson]
Sun Life Financial (NYSE: SLF) shares gained 2.47% to create a new 52-week high of $34.80 on Q3 results. Sun Life reported its Q3 operating net income from continuing operations of $422 million.
Hot Rising Stocks To Buy For 2014: Demand Media Inc. (DMD)
Demand Media, Inc. operates as an Internet media and domain services company worldwide. The company focuses on an Internet-based model for the professional creation and distribution of content at scale. It offers content and media, and registrar services. The company�s content and media services include creating media content primarily consisting of text articles and videos, and delivering together with its social media and monetization tools to the company's owned and operated Websites and mobile applications, and network of customer Websites and their mobile applications to publishers, brands, and retailers. Its content and media services are delivered through the company's content and media platform, which includes its content creation studio, social media applications, and a system of monetization tools designed to match content with advertisements. The company deploys its content and media platform to it�s owned and operated Websites, such as eHow.com, LIVESTRONG.CO M, and Cracked.com, as well as to Websites operated by its customers. Its registrar service offering provides domain name registration and related value added services, such as third-party Website security services, identification protection services, Web hosting plans, customizable email accounts, and business listing services to resellers, including small businesses, e-commerce Websites, Internet service providers, Web-hosting companies, and retail consumers. Demand Media, Inc. was founded in 2006 and is headquartered in Santa Monica, California.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 Internet services player that's starting to move within range of triggering a near-term breakout trade is Demand Media (DMD), which focuses on an Internet-based model for the professional creation and distribution of content at scale. This stock has been hit hard by the bears so far in 2013, with shares off by 44%.
If you take a look at the chart for Demand Media, you'll notice that this stock has recently formed a triple bottom over the last month, with shares finding buying interest at $4.80, $4.72 and $4.88 a share. Shares of DMD have now started to spike higher off those support levels, and the stock is quickly moving within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in DMD if it manages to break out above some near-term overhead resistance levels at $5.39 to $5.46 and then once it takes out its 50-day moving average at $5.76 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 681,665 shares. If that breakout hits soon, then DMD will set up to re-test or possibly take out its next major overhead resistance levels at $6.50 to $7 a share. Any high-volume move above $7.14 would then give DMD a chance to re-fill some of its previous gap down zone from June that started near $8.50 a share.
Traders can look to buy DMD off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $4.88 or at $4.72 a share. One can also buy DMD off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Lisa Levin]
Demand Media (NYSE: DMD) shares reached a new 52-week low of $4.23. Demand Media is expected to announce its Q1 results on May 8, 2014.
Express (NYSE: EXPR) shares fell 2.49% to touch a new 52-week low of $14.28. Express shares have dropped 14.83% over the past 52 weeks, while the S&P 500 index has gained 20.97% in the same period.
Hot Rising Stocks To Buy For 2014: Boston Scientific Corp (BSX)
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women�� Health, Neuromodulation, and Electrophysiology. In January 2011, it completed the acquisition of Intelect Medical, Inc. In January 2011, it completed the acquisition of Sadra Medical, Inc. In March 2011, the Company completed the acquisition of Atritech, Inc. In February 2011, it announced the acquisitions of S.I. Therapies and ReVascular Therapeutics, Inc. In January 2011, the Company sold its Neurovascular business to Stryker Corporation. In June 2012, the Company acquired Cameron Health, Inc. of San Clemente, California and, as a result, added to its product portfolio subcutaneous implantable cardioverter defibrillator, called the S-ICD System.
Interventional Cardiology
The Company offers coronary stent product. Coronary stents are tiny, mesh tubes used in the treatment of coronary artery disease, which are implanted in patients to prop open arteries and facilitate blood flow to and from the heart. The Company offers a two-drug platform strategy with its paclitaxel-eluting and everolimus-eluting stent system offerings, and it offers a range of stent sizes. The Company markets its next-generation internally-developed and self-manufactured PROMUS Element stent system in the United States, its Europe/Middle East/Africa (EMEA) region and certain Inter-Continental countries, including China and India. It markets the PROMUS everolimus-eluting stent system, supplied to the Company by Abbott Laboratories, in Japan. It also markets its TAXUS paclitaxel-eluting stent line, including its third-generation TAXUS Element paclitaxel-eluting stent system in the U.nited States, Japan, EMEA and certain Inter-Continental countries.
The Compa! ny markets a line of products used to treat patients with atherosclerosis, a principal cause of coronary artery obstructive disease. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA). The Company markets a family of intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels. The iLab Ultrasound Imaging System continues as its flagship console and is compatible with its line of imaging catheters. The system is designed to enhance the diagnosis and treatment of blocked vessels and heart disorders. Sadra is developing a repositionable and retrievable device for transcatheter aortic valve replacement (TAVR) to treat patients with severe aortic stenosis. The Lotus Valve System consists of a stent-mounted tissue valve prosthesis and catheter delivery system for guidance and placement of the valve. Atritech has developed a device designed to close the left atrial appendage in patients with atrial fibrillation who are at risk for ischemic stroke. The WATCHMAN Left Atrial Appendage Closure Technology, developed by Atritech, is the first device proven in a randomized clinical trial to offer an alternative to anticoagulant drugs, and is approved for use in CE Mark countries.
Cardiac Rhythm Management
The Company develops, manufactures and markets a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, including Implantable cardioverter defibrillator (ICD) systems used to detect and treat abnormally fast heart rhythms (tachycardia) that could result in sudden cardiac death, including implantable cardiac resynchronization therapy defibrillator (CRT-D) systems used to treat heart failure, and implantable pacemaker systems used to manage slow or irregular heart rhyth! ms (brady! cardia), including implantable cardiac resynchronization therapy pacemaker (CRT-P) systems used to treat heart failure. Its product offerings include its COGNIS cardiac resynchronization therapy defibrillator (CRT-D), its TELIGEN ICD systems and its ALTRUA family of pacemaker systems. During 2011, it began the United States launch of its next-generation line of defibrillators, INCEPTA, ENERGEN and PUNCTUA.
Endoscopy
The Company markets a range of products to diagnose, treat and ease a variety of digestive diseases, including those affecting the esophagus, stomach, liver, pancreas, duodenum, and colon. Common disease states include esophagitis, portal hypertension, peptic ulcers as well as esophageal, biliary, pancreatic and colonic cancer. The Company offers the Radial Jaw 4 Single-Use Biopsy Forceps, which are designed to enable collection of large high-quality tissue specimens without the need to use large channel therapeutic endoscopes. Its exclusive line of RX Biliary System devices are designed to provide greater access and control for physicians to diagnose and treat challenging conditions of the bile ducts, such as removing gallstones, opening obstructed bile ducts and obtaining biopsies in suspected tumors. The Company also markets the Spyglass Direct Visualization System for direct imaging of the pancreatico-biliary system. The Spyglass System is a single-operator cholangioscopy device that offers clinicians a direct visualization of the pancreatico-biliary system and includes supporting devices for tissue acquisition, stone management and lithotripsy. Its products also include the WallFlex family of stents, in particular, the WallFlex Biliary line and WallFlex Esophageal line; and in 2011, the Company launched its Advanix Biliary Plastic Stent System and the Expect Endoscopic Ultrasound Aspiration Needle in the United States and certain international markets. Its Resolution Clip Device is an endoscopic mechanical clip designed to treat gastrointestinal bleeding.
T! he Company markets devices to diagnose, treat and ease pulmonary disease systems within the airway and lungs. Its products are designed to help perform biopsies, retrieve foreign bodies from the airway, open narrowings of an airway, stop internal bleeding, and ease symptoms of some types of airway cancers. Its product line includes pulmonary biopsy forceps, transbronchial aspiration needles, cytology brushes and tracheobronchial stents used to dilate narrowed airway passages or for tumor management. Asthmatx, Inc. designs, manufactures and markets a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma. The Alair Bronchial Thermoplasty System, developed by Asthmatx, has both CE Mark and Food and Drug Administration (FDA) approval and is the first device-based asthma treatment approved by the FDA.
Peripheral Interventions
The Company sells various products designed to treat patients with peripheral disease, including a line of medical devices used in percutaneous transluminal angioplasty and peripheral vascular stenting. Its peripheral product offerings include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters. In 2010 and 2011, it launched several of its products internationally, including the EPIC self-expanding nitinol stent system in certain international markets, and the Carotid WALLSTENT stent system in Japan. The Company launched three new peripheral angioplasty balloons in 2011, including its next-generation Mustang percutaneous transluminal angioplasty (PTA) balloon, its Coyote balloon catheter, a highly deliverable and ultra-low profile balloon dilatation catheter designed for a range of peripheral angioplasty procedures and its Charger PTA Balloon Catheter, a 0.035 inch percutaneous transluminal angioplasty balloon catheter designed for post-stent dilatation, as well as conventional balloon angioplasty to open blocked peripheral arteries. The Company has commenced a limited ma! rket rele! ase of its OFFROAD re-entry catheter system in certain international markets, and in February 2012, it launched its TRUEPATH intraluminal CTO device in the United States.
The Company sells products designed to treat patients with non-vascular disease. Its non-vascular suite of products include biliary stents, drainage catheters and micro-puncture sets designed to treat, diagnose and ease various forms of benign and malignant tumors. The Company continues to market its extensive line of Interventional Oncology product solutions, including the Renegade HI-FLO Fathom microcatheter and guidewire system and Interlock - 35 Fibered IDC Occlusion System for peripheral embolization. The Company�� FilterWire EZ Embolic Protection System is a filter designed to capture embolic material that may become dislodged during a procedure, which could otherwise travel into the microvasculature where it could cause a heart attack or stroke. It is commercially available in the United States, its EMEA region and certain Inter-Continental countries for multiple indications, including the treatment of disease in peripheral, coronary and carotid vessels. It is also available in the United States for the treatment of saphenous vein grafts and carotid artery stenting procedures.
Urology/Women�� Health
The Company�� Urology/Women�� Health division develops, manufactures and sells devices to treat various urological and gynecological disorders. The Company sells a variety of products designed to treat patients with urinary stone disease, stress urinary incontinence, pelvic organ prolapse and excessive uterine bleeding. The Company offers a line of stone management products, including ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons and catheters.
The Company markets a range of devices for the treatment of conditions, such as female urinary incontinence, pelvic floor reconstruction (rebuilding of the anatomy to its original state), and ! menorrhag! ia (excessive menstrual bleeding). It offers a breadth of mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices. The Company markets its Genesys Hydro ThermAblator (HTA) system, a next-generation endometrial ablation system designed to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia. The Genesys HTA System features a smaller and lighter console, simplified set-up requirements, and an enhanced graphic user interface and is designed to improve operating performance.
Neuromodulation
The Company within its Neuromodulation business markets the Precision Spinal Cord Stimulation (SCS) system, used for the management of chronic pain. In 2011, the Company launched its Clik Anchor for its Precision Plus SCS System, a rechargeable SCS device for chronic pain management. During 2011, it received FDA approval for and launched the Infinion 16 Percutaneous Lead, a 16-contact percutaneous lead. The Company also markets the Linear 3-4 and Linear 3-6 Percutaneous Leads for use with its SCS systems, which are designed to provide physicians more treatment options for their chronic pain patients. Intelect Medical, Inc. is a development-stage company developing advanced visualization and programming for the Vercise system.
Electrophysiology
The Company within its Electrophysiology business develops less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart. Included in its product offerings are radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Its products include the Blazer and Blazer Prime line of temperature ablation catheters, designed to deliver enhanced performance, responsiveness, and durability. Its cooled ablation portfolio includes the closed-loop irrigated catheter on the market, the Chilli II cooled! ablation! catheter, and the newly launched Blazer Open-Irrigated ablation catheter with a Total Tip Cooling Design.
The Company competes with Abbott Laboratories, Medtronic, Inc., St. Jude Medical, Inc. and Johnson & Johnson.
Advisors' Opinion:- [By Johanna Bennett]
With its stock price already doubled in value over the last 12 months, is it time to back away from shares of Boston Scientific (BSX)? Cowen & Co. analyst Joshua Jennings doesn�� think so.
- [By Holly LaFon]
The stocks he did buy in the fourth quarter are almost all large positions. The largest, Boston Scientific (BSX), is 5.4 percent of his portfolio. He bought 7,797,503 shares at an average price of $5.50. The stock has declined over 20 percent in the last year and 65 percent over the last five years. The company has had volatile free cash flow over the last ten years and declining annual revenue since 2007. However, it has cut expenses (including jobs), is investing in China, and is launching two dozen new devices in 2012, in an effort to increase earnings by double digits in the next five years. Year to date, the stock is up 12 percent.
- [By EquityOptionsGuru]
The Prolieve Thermodilatation System was actually developed by the current management of Medifocus while employed at Celsion Corporation (NASDAQ:CLSN). The system was also jointly developed with Boston Scientific (NYSE:BSX) before being acquired by Medifocus in July 2012. Prolieve has already received FDA approval, is currently generating revenue, and is the only in office alternative to drug therapy. The system essentially uses microwave energy to treat Benign Prostatic Hyperplasia (BPH), which is a non-cancerous enlargement of the prostate gland that typically affects men over the age of 50. The Prolieve device works by compressing and heating prostatic tissue that may be blocking the flow of urine. This particular treatment option offers patients several benefits including the following:
- [By Ben Levisohn]
Boston Scientific (BSX) has dropped 4.2% to $10.81, making it the second-biggest loser in the S&P 500, while Zions Bancorp (ZION) has fallen 4.1% to $28.03.
Hot Rising Stocks To Buy For 2014: Intermolecular Inc (IMI)
Intermolecular, Inc. (Intermolecular), incorporated on June 16, 2004, is engaged in research and development and time-to-market for the semiconductor and clean-energy industries. The Company, through paid collaborative development programs (CDPs) with its customers, develops technology and intellectual property (IP) for its customers focused on advanced materials, processes, integration and device architectures. The Company provides its customers with technology through various fee arrangements and grants them rights to associated IP, primarily through royalty-bearing licenses. Through paid CDPs and its own development, the Company has established a portfolio of greater than 1,000 patents and patent applications. Its approach is broadly applicable to high-volume integrated device markets, which include the markets for semiconductors, flat glass coatings and glass-based devices, solar cells, light-emitting diodes (LEDs), flat-panel displays, advanced batteries and other energy efficiency applications.
As of December 31, 2012, the Company targets large, high-volume semiconductor and high-growth emerging clean energy markets, including DRAM, non-volatile memory (including flash memory and embedded memory), complex logic, flat glass coatings and glass-based devices, solar cells, LEDs and other energy efficiency applications. The Company�� customers include ATMI, Inc. (ATMI), Elpida Memory, Inc. (Elpida), First Solar. Inc. (First), GLOBALFOUNDRIES Singapore Pte. Ltd (GLOBALFOUNDRIES), Guardian Industries Corp. (Guardian), SanDisk Corporation (SanDisk), Taiwan Semiconductor Manufacturing Company (TSMC) and Toshiba Corporation (Toshiba). For the year ended December 31, 2012, the Company has received the majority of its revenue from customers in DRAM, flash memory, complex logic and energy-efficient applications in flat glass. The elements in HPC platform include Tempus HPC processing, automated characterization, and informatics and analysis software. Tempus HPC processing are used to process ! different experiments consisting of combinations of materials, processing parameters, sequencing and device structures. Automated characterization systems are used to characterize the substrates processed by its Tempus HPC processing tools. Informatics and analysis software are used to automate experiment generation, characterization, data analysis and reporting.
The Company�� HPC platform consists of its Tempus HPC processing tools, automated characterization and informatics and analysis software. The Company�� platform is purpose-built for Research and Development (R and D) using combinatorial process systems. Combinatorial processing is a methodology for discovery and development that employs parallel and other high-throughput experimentation, which allows R and D experimentation to be performed at speeds up to 100 times faster than traditional methods. The Company�� processing tools allows performing up to 192 experiments on a single substrate.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Technology shares gained about 0.68 percent in today's trading. Meanwhile, top gainers in the sector included Intermolecular (NASDAQ: IMI), up 38.3 percent, and Infinera (NASDAQ: INFN), up 9.4 percent. In trading on Monday, utilities shares were relative laggards, down on the day by about 0.68 percent. - [By Lisa Levin]
Intermolecular (NASDAQ: IMI) shares touched a new 52-week low of $4.84. Intermolecular shares have dropped 45.09% over the past 52 weeks, while the S&P 500 index has gained 26.39% in the same period.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Technology shares gained about 0.68 percent in today's trading. Meanwhile, top gainers in the sector included Intermolecular (NASDAQ: IMI), up 38.3 percent, and Infinera (NASDAQ: INFN), up 9.4 percent. In trading on Monday, utilities shares were relative laggards, down on the day by about 0.68 percent.
Hot Rising Stocks To Buy For 2014: DineEquity Inc (DIN)
DineEquity, Inc., incorporated on May 07, 1976, owns franchise and operate two restaurant concepts: Applebee's Neighborhood Grill & Bar, (Applebee's), in the bar and grill segment of the casual dining category of the restaurant industry, and International House of Pancakes (IHOP), in the family dining category of the restaurant industry. As of December 31, 2012, the franchise operations segment consisted of 2,011 restaurants operated by Applebee's franchisees in the United States, one United States territory and 15 foreign countries and 1,569 restaurants operated by IHOP franchisees and area licensees in the United States, two United States territories and five foreign countries. As of December 31, 2012, the Company restaurant operations segment consisted of 23 Applebee's Company-operated restaurants, 10 IHOP Company-operated restaurants and two IHOP restaurants reacquired from franchisees and operated by IHOP on a temporary basis until refranchised. Financing operations revenue primarily consists of interest income from the financing of franchise fees and equipment leases, as well as sales of equipment associated with refranchised IHOP restaurants and a portion of franchise fees for restaurants taken back from franchisees not allocated to IHOP intellectual property. In October 2012, it completed the refranchising program and completed the transitioning to a 99% franchised restaurant system.
Applebee's
The Company develops, franchises and operates restaurants in the bar and grill segment of the casual dining category of the restaurant industry under the name Applebee's Neighborhood Grill & Bar. As of December 31, 2012, 68 franchise groups operated 2,011 of these restaurants and 23 restaurants were Company-operated. The restaurants were located in 49 states, one United States territory and 15 countries outside of the United States. During the year ended December 31, 2012, 20 domestic franchise restaurants opened, six domestic franchise restaurants closed. 154 Company-operated! restaurants were franchised. The number of restaurants held by an individual franchisee ranges from one to 438 restaurants. As of December 31, 2012, it is focusing on international franchising primarily in Canada, Mexico, Central and South America, and the Mediterranean/Middle East. As of December 31, 2012, there were 149 international Applebee's franchise restaurants. During 2012, 14 international franchise restaurants opened and 13 international franchise restaurants closed.
IHOP
The Company develops franchises and operates restaurants in the family dining category of the restaurant industry under the names IHOP and International House of Pancakes. As of December 31, 2012 there were a total of 1,581 IHOP restaurants of which 1,404 were subject to franchise agreements, 165 were subject to area license agreements, 10 were Company-operated restaurants and two restaurants were reacquired from franchisees and operated by IHOP on a temporary basis. The Company owns and operates 10 IHOP restaurants in the Cincinnati market area primarily to test new remodel programs, operating procedures, products, technology, cooking platforms and service models. IHOP restaurants are located in all 50 states of the United States, the District of Columbia, Puerto Rico and the United States Virgin Islands and internationally in Canada, the Dominican Republic, Guatemala, Mexico and the United Arab Emirates. As of December 31, 2012, the area licensee for the state of Florida and certain counties in Georgia operated or sub-franchised a total of 152 IHOP restaurants, and the area licensees for the province of British Columbia, Canada operated or sub-franchised a total of 13 IHOP restaurants. As of December 31, 2012, the Company had signed commitments and options from franchisees to build 245 IHOP restaurants over the next 17 years, comprised of 5 restaurants under single-restaurant or non-traditional development agreements, 120 restaurants under multi-restaurant development agreements and 63 restaurants! under in! ternational development agreements. As of December 31, 2012, there were 1,525 domestic IHOP franchise and area license restaurants. During 2012, its franchisees and area licensees opened 40 domestic franchise restaurants and 17 domestic franchise and area license restaurants were closed. As of December 31, 2012, there were 44 international IHOP franchise and area license restaurants. During 2012, its franchisees opened eight international franchise restaurants and no restaurants were closed.
The Company competes with Chili's, T.G.I. Friday's, Ruby Tuesday's, Denny's, Cracker Barrel Old Country Store and Bob Evans Restaurants.
Advisors' Opinion:- [By Caroline Bennett]
Restaurant company DineEquity (NYSE: DIN ) has announced plans to keep its dividend steady this quarter at $0.75 per share of common stock. This is the same amount the company has paid its shareholders since March 2013, after upping the payout by $0.50, from $0.25 per share.
- [By Rick Aristotle Munarriz]
Bo Rader/Wichita Eagle/MCT via Getty Images In the food world, pumpkin is the new black. The squash offshoot that was once relegated to jack o' lanterns on Halloween and whipped into pies for Thanksgiving is experiencing a foodie renaissance. A lot of coffee houses, restaurants, and fast food chains are embracing the pumpkin for a seasonal spark on their menus. Here are some of the many ways that consumers are enjoying pumpkin this season at publicly traded eateries. Starbucks (SBUX) It's safe to say that pumpkins had arrived as a trendy menu add-on when Starbucks introduced them into its seasonal latte line. The Starbucks Pumpkin Spice Latte is a combination of espresso, steamed milk, and pumpkin-flavored syrup -- topped with whipped cream and pumpkin pie spices. It's as decadent as it sounds. A venti-sized offering made with whole milk clocks in at 510 calories and a whopping 12 grams of saturated fat -- 60 percent of the recommended daily fat intake in a single cup. But you can nix the whipped cream and go with skim milk for a fat-free indulgence. How popular is the drink? Starbucks claims to have sold 200 million of them over the years before it began pouring them out last month. The grande 16-ounce option will set you back $4.55, on average (prices do vary from location to location). McDonald's (MCD) It's been a few years since the world's largest fast food chain ripped a page out of the Starbucks playbook with its McCafe line of premium coffee beverages. This season, it's moving a step closer to Starbucks by offering its own Pumpkin Spice Latte. McDonald's knows how to price its offerings aggressively. It's 16-ounce version sells for $2.89, and it will be available through mid-November. It's not the only way that McDonald's is playing up the gourd this season. Customers can also order a pumpkin pie treat, served in the same turnover style as its baked apple pie. Jamba (JMBA) You know it's fall when pumpkin finds its way into Jamba Juice's blender
Hot Rising Stocks To Buy For 2014: CombiMatrix Corporation(CBMX)
CombiMatrix Corporation, a molecular diagnostics company, operates primarily in the fields of genetic analysis and molecular diagnostics in the United States. The company, through its wholly owned subsidiary, CombiMatrix Diagnostics, operates a diagnostics reference laboratory that provides DNA-based clinical diagnostic testing services to physicians, hospitals, and other laboratories in two primary areas, including prenatal and postnatal developmental disorders, and oncology. It offers a suite of developmental disorder array tests on the prenatal and postnatal application of array-comparative genomic hybridization in diagnosing genomic syndromes associated with developmental delays, autism spectrum disorders, dysmorphic features, and/or birth defects. The company also provides DNAarray?Heme Profile test to address various common hematological malignancies, including chronic lymphocytic leukemia; DNAarray?HER2 PRO test for breast cancer; and DNAarray?Tumor Profile test for the analysis of solid tumors, including breast, colon, lung, prostate, and brain tumors. In addition, it focuses on developing a series of drug compounds to address various oncology-related diseases. CombiMatrix Corporation was founded in 1995 and is based in Irvine, California.
Advisors' Opinion:- [By Wallace Witkowski]
Also, shares of Combimatrix Corp. (CBMX) rose 7.5% to $2.73 in moderate volume late Friday following a Securities and Exchange Commission filing showing Longwood Capital Partners acquired a 5.1% stake in the microcap molecular diagnostics company.
Hot Rising Stocks To Buy For 2014: Swedbank AB (SWDBY.PK)
Swedbank AB is the parent company of Swedbank. Swedbank consists of subsidiaries, associates and a joint venture. The Company operates in six business areas: Swedish Banking, Baltic Banking, International Banking, Swedbank Markets, Asset Management and Ektornet. On January 20, 2009, Swedbank Robur AB acquired Banco Fonder AB from Alfred Berg. In February 2010, the Company acquired a 15% equity stake in OAO Swedbank from European Bank for Reconstruction and Development (EBRD). During the year ended December 31, 2009, Swedbank sold four branches to Sparbanken Nord, three branches to Sparbanken Dalsland, two branches to Sparbanken Rekarne, one branch to Tidaholms Sparbank and one branch to Sparbanken 1826.
Swedish Banking
Swedish Banking is engaged in offering a range of financial products and services to private customers, corporates, organisations and municipalities through close to 400 branches, as well as the telephone bank and Internet bank in Sweden. Swedbank�� products are also sold through the cooperating savings banks, which account for another 275 branches. The subsidiary in Luxembourg, with a representative office in Spain is included in the business area as well.
Baltic Banking
Baltic Banking offers a range of financial products and services to private and corporate customers in Estonia, Latvia and Lithuania. It offers its services through 226 branches, as well as the telephone bank and Internet bank.
International Banking
International Banking consists of operations outside Swedbank�� home markets, primarily the banking operations in Ukraine and Russia. In addition to Ukraine and Russia, the business area includes the branches in Denmark, Norway, the United States and China, as well as the representative office in Japan. The branch network in Ukraine, consists of 156 branches, serves both private and corporate customers. The Nordic branches offer corporate customers, mainly Swedish customers with operations in! the Nordic markets, a range of financial products and services.
Swedbank Markets
Swedbank Markets has operations in equity, fixed income and currency trading, corporate finance, as well as project, export and acquisition financing. In addition to its operations in Swedbank�� home markets, the business area includes the subsidiaries First Securities ASA in Norway and Swedbank First Securities LLC in New York.
Asset Management
Asset Management, which consists of the subsidiary Swedbank Robur Group, offers services in fund management, institutional and discretionary asset management in all of Swedbank�� home markets. Its customers include private customers, as well as institutions, foundations, municipalities, county councils and other investors. Its products are sold and distributed primarily by Swedish Banking and Baltic Banking and the savings banks in Sweden.
Ektornet
Ektornet is an independent subsidiary of Swedbank AB. It focuses on managing the Company�� repossessed assets and developing them over time. Most of the collateral consists of real estate, the part of which will be in the Baltic countries, though also in the Nordic region and the United States.
Advisors' Opinion:- [By David Hunkar]
Current Dividend Yield: 5.16%
Company: Swedbank AB (SWDBY.PK)
Sector: Oil, Gas & Consumable Fuels
Country: FranceCurrent Dividend Yield: 6.50%
Sector: Banking
Country: Sweden
No comments:
Post a Comment